AMD shares slipped nearly 3% during pre-market trading on Friday. It has declined 31% over the past six months. Goldman Sachs ...

Rhythm Pharmaceuticals reports strong global sales for IMCIVREE in Q4 and FY 2024, with pipeline advancements and upcoming Phase 3 trial milestones.

The case of petrochemicals is even worse. With Argentinian prices skyrocketing in dollars (CoGS up 25% YoY on USD for Pampa), ...

ProShares Ultra S&P500 ETF ( NYSEARCA: SSO) is one of those rare leveraged exchange traded funds which has generated gobsmacking returns over the past decade, mostly due to the impressive performance ...

I have a hold rating on SCHG due to stretched valuations and technical signals suggesting potential consolidation or ...

The SCHG ETF has a strong contribution from technology companies, and together with the S&P 500, it brought a strong return ...

GHM has shown revenue and return improvements post-2021 due to new management and M&A strategy, but 2025 profits remain lower ...

Explore the impact of the Fed Funds Rate on U.S. monetary policy and how it has evolved post-GFC, shifting focus to IORB and ...

Shell plc ( NYSE: SHEL) is a multinational oil and gas company based out of the UK. Because of the company's market cap of ...

I maintain a "Buy" rating for A.P. Moller Maersk with a target price of 13,500 DKK/share, viewing it as a long-term ...

Discover how AI and data center growth are fueling Energy Transfer LP's success, with strong pipeline positioning and a 6.7% yield. Click for my ET update.

There are great opportunities among dividend stocks. Click here to find out one of my largest holdings going into 2025.